Geographic Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast  2024-2034

Geographic Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Report Format: PDF+Excel | Report ID: SR112024A6609
Buy Now

Market Overview:

The 7 major geographic atrophy markets reached a value of US$ 24.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 44.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.7% during 2024-2034.

Report Attribute
Key Statistics
Base Year 
2023
Forecast Years  2024-2034
Historical Years 
2018-2023
Market Size in 2023
US$ 24.2 Billion
Market Forecast in 2034
US$ 44.5 Billion
Market Growth Rate 2024-2034 5.7%


The geographic atrophy market has been comprehensively analyzed in IMARC’s new report titled “Geographic Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034”. Geographic atrophy is an advanced form of dry age-related macular degeneration that affects the retina, a part of the eye that sends information to the brain to enable sight. In this stage, the damage is so severe that it causes blind spots in the patient’s central vision. A patient can have both wet and dry age-related macular degeneration simultaneously and develop geographic atrophy independently of having wet age-related macular degeneration. This disease leads to sharply demarcated atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. The common symptoms experienced by patients are central vision loss, difficulty in low-light conditions, and trouble seeing colors. Initially, the sign is identified while reading when one or several letters are missing from a word or when looking at faces, a small region of the face is not clearly visible. Over several years, geographic atrophy causes the central vision to diminish and the visual acuity comes down to 20/200. However, it does not usually affect peripheral vision. Geographic atrophy can be identified by an ophthalmologist using retinal imaging and a dilated examination. In a dilated exam, geographic atrophy appears as a patch of the retina without dark melanin pigment. Imaging techniques can also be used to detect geographic atrophy, including optical coherence tomography (OCT), retinal color photographs, autofluorescence imaging, etc.

Geographic Atrophy Market

The increasing prevalence of retinal disorders along with the expanding geriatric population is primarily driving the geographic atrophy market. Additionally, the rising incidences of obesity and cardiovascular diseases (CVDs) on account of changing dietary patterns, sedentary lifestyles, and unhealthy habits like smoking are further creating a positive outlook for the market. In line with this, the escalating usage of smartphones, laptops, televisions, etc., which is leading to prolonged and excessive screen time, is also propelling the market growth. Moreover, the introduction of retinal gene therapies, which involve injecting adeno-associated virus (AAV) into the body to prevent the development of abnormal blood vessels, is further acting as a significant growth-inducing factor. Besides this, the widespread adoption of autofluorescence imaging technology to visualize the retinal pigment epithelium (RPE) in order to assess the progression rate of the disease is also bolstering the global market. Additionally, several key players are making substantial investments in developing imaging technologies that will contribute to the understanding of the genesis and pathophysiological mechanisms of geographic atrophy. This, in turn, is positively influencing the market growth. Numerous other factors, such as extensive R&D activities for launching innovative and effective drugs and the increasing expenditure on healthcare to facilitate access to affordable treatment options, are expected to drive the geographic atrophy market in the coming years.

IMARC Group’s new report provides an exhaustive analysis of the geographic atrophy market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report the United States has the largest patient pool for geographic atrophy and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the geographic atrophy market in any manner.

Time Period of the Study

  • Base Year: 2023
  • Historical Period: 2018-2023
  • Market Forecast: 2024-2034
     

Countries Covered

  • United States
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Japan
     

Analysis Covered Across Each Country

  • Historical, current, and future epidemiology scenario
  • Historical, current, and future performance of the geographic atrophy market
  • Historical, current, and future performance of various therapeutic categories in the market
  • Sales of various drugs across the geographic atrophy market
  • Reimbursement scenario in the market
  • In-market and pipeline drugs

Competitive Landscape:

This report also provides a detailed analysis of the current geographic atrophy marketed drugs and late-stage pipeline drugs.

In-Market Drugs

  • Drug overview
  • Mechanism of action
  • Regulatory status
  • Clinical trial results
  • Drug uptake and market performance
     

Late-Stage Pipeline Drugs

  • Drug overview
  • Mechanism of action
  • Regulatory status
  • Clinical trial results
  • Drug uptake and market performance
     
Drugs Company Name
Pegcetacoplan Apellis Pharmaceuticals/Swedish Orphan Biovitrum
Avacincaptad Pegol IVERIC bio
Metformin  
Retinol deuterated Alkeus Pharmaceuticals
Iptacopan Novartis Pharmaceuticals


*Kindly note that the drugs in the above table only represent a partial list of marketed/pipeline drugs, and the complete list has been provided in the report.

Key Questions Answered in this Report:

Market Insights

  • How has the geographic atrophy market performed so far and how will it perform in the coming years?
  • What are the markets shares of various therapeutic segments in 2023 and how are they expected to perform till 2034?
  • What was the country-wise size of the geographic atrophy market across the seven major markets in 2023 and what will it look like in 2034?
  • What is the growth rate of the geographic atrophy market across the seven major markets and what will be the expected growth over the next ten years?
  • What are the key unmet needs in the market?
     

Epidemiology Insights

  • What is the size of the geographic atrophy patient pool (​2018-2023​) across the seven major markets?
  • What would be the forecasted patient pool (​2024-2034​) across the seven major markets?
  • What are the key factors driving the epidemiological trend of geographic atrophy?
  • What will be the growth rate of patients across the seven major markets?
     

Geographic Atrophy: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

  • What are the current marketed drugs and what are their market performance?
  • What are the key pipeline drugs and how are they expected to perform in the coming years?
  • How safe are the current marketed drugs and what are their efficacies?
  • How safe are the late-stage pipeline drugs and what are their efficacies?
  • What are the current treatment guidelines for geographic atrophy drugs across the seven major markets?
  • Who are the key companies in the market and what are their market shares?
  • What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the geographic atrophy market?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Geographic Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast  2024-2034
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More